176 related articles for article (PubMed ID: 20379545)
21. Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.
Zeng L; Ren W; Zheng J; Cui P; Wu A
Phys Chem Chem Phys; 2012 Feb; 14(8):2631-6. PubMed ID: 22273844
[TBL] [Abstract][Full Text] [Related]
22. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.
Amstad E; Zurcher S; Mashaghi A; Wong JY; Textor M; Reimhult E
Small; 2009 Jun; 5(11):1334-42. PubMed ID: 19242944
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Ma HL; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
[TBL] [Abstract][Full Text] [Related]
24. Properties of superparamagnetic iron oxide nanoparticles assembled on nucleic acids.
Tanaka K; Kitamura N; Chujo Y
Nucleic Acids Symp Ser (Oxf); 2008; (52):693-4. PubMed ID: 18776569
[TBL] [Abstract][Full Text] [Related]
25. Controlling phase formation in solids: rational synthesis of phase separated Co@Fe2O3 heteroparticles and CoFe2O4 nanoparticles.
Nakhjavan B; Tahir MN; Panthöfer M; Gao H; Gasi T; Ksenofontov V; Branscheid R; Weber S; Kolb U; Schreiber LM; Tremel W
Chem Commun (Camb); 2011 Aug; 47(31):8898-900. PubMed ID: 21748171
[TBL] [Abstract][Full Text] [Related]
26. Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents.
Rebolledo AF; Laurent S; Calero M; Villanueva A; Knobel M; Marco JF; Tartaj P
ACS Nano; 2010 Apr; 4(4):2095-103. PubMed ID: 20355739
[TBL] [Abstract][Full Text] [Related]
27. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
Martin AR; Thompson RB; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
[TBL] [Abstract][Full Text] [Related]
28. Cyano-bridged coordination polymer nanoparticles with high nuclear relaxivity: toward new contrast agents for MRI.
Guari Y; Larionova J; Corti M; Lascialfari A; Marinone M; Poletti G; Molvinger K; Guérin C
Dalton Trans; 2008 Jul; (28):3658-60. PubMed ID: 18615211
[TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging.
Liu F; Laurent S; Fattahi H; Vander Elst L; Muller RN
Nanomedicine (Lond); 2011 Apr; 6(3):519-28. PubMed ID: 21542689
[TBL] [Abstract][Full Text] [Related]
30. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
[TBL] [Abstract][Full Text] [Related]
31. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.
Lu J; Ma S; Sun J; Xia C; Liu C; Wang Z; Zhao X; Gao F; Gong Q; Song B; Shuai X; Ai H; Gu Z
Biomaterials; 2009 May; 30(15):2919-28. PubMed ID: 19230966
[TBL] [Abstract][Full Text] [Related]
32. Relaxation behavior study of ultrasmall superparamagnetic iron oxide nanoparticles at ultralow and ultrahigh magnetic fields.
Wang W; Dong H; Pacheco V; Willbold D; Zhang Y; Offenhaeusser A; Hartmann R; Weirich TE; Ma P; Krause HJ; Gu Z
J Phys Chem B; 2011 Dec; 115(49):14789-93. PubMed ID: 21972868
[TBL] [Abstract][Full Text] [Related]
33. Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.
Casula MF; Corrias A; Arosio P; Lascialfari A; Sen T; Floris P; Bruce IJ
J Colloid Interface Sci; 2011 May; 357(1):50-5. PubMed ID: 21345440
[TBL] [Abstract][Full Text] [Related]
34. Linear assemblies of magnetic nanoparticles as MRI contrast agents.
Corr SA; Byrne SJ; Tekoriute R; Meledandri CJ; Brougham DF; Lynch M; Kerskens C; O'Dwyer L; Gun'ko YK
J Am Chem Soc; 2008 Apr; 130(13):4214-5. PubMed ID: 18331033
[TBL] [Abstract][Full Text] [Related]
35. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.
Lee PW; Hsu SH; Wang JJ; Tsai JS; Lin KJ; Wey SP; Chen FR; Lai CH; Yen TC; Sung HW
Biomaterials; 2010 Feb; 31(6):1316-24. PubMed ID: 19959224
[TBL] [Abstract][Full Text] [Related]
36. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
37. Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis.
Schellenberger E; Schnorr J; Reutelingsperger C; Ungethüm L; Meyer W; Taupitz M; Hamm B
Small; 2008 Feb; 4(2):225-30. PubMed ID: 18203233
[TBL] [Abstract][Full Text] [Related]
38. Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
Zhang C; Wängler B; Morgenstern B; Zentgraf H; Eisenhut M; Untenecker H; Krüger R; Huss R; Seliger C; Semmler W; Kiessling F
Langmuir; 2007 Jan; 23(3):1427-34. PubMed ID: 17241069
[TBL] [Abstract][Full Text] [Related]
39. Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents.
Meng XX; Wan JQ; Jing M; Zhao SG; Cai W; Liu EZ
Acta Pharmacol Sin; 2007 Dec; 28(12):2019-26. PubMed ID: 18031618
[TBL] [Abstract][Full Text] [Related]
40. Superparamagnetic iron oxide nanoparticles for MRI: contrast media pharmaceutical company R&D perspective.
Corot C; Warlin D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):411-22. PubMed ID: 23633290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
